...
首页> 外文期刊>BMJ Open >Prevalence of c.2268dup and detection of two novel alterations, c.670_672del and c.1186CT, in the TPO gene in a cohort of Malaysian–Chinese with thyroid dyshormonogenesis
【24h】

Prevalence of c.2268dup and detection of two novel alterations, c.670_672del and c.1186CT, in the TPO gene in a cohort of Malaysian–Chinese with thyroid dyshormonogenesis

机译:马来西亚华裔甲状腺功能异常发生人群中TPO基因中c.2268dup的流行和两个新变化c.670_672del和c.1186C> T的检测

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives The c.2268dup mutation in the thyroid peroxidase (TPO) gene is the most common TPO alteration reported in Taiwanese patients with thyroid dyshormonogenesis. The ancestors of these patients are believed to originate from the southern province of China. Our previous study showed that this mutation leads to reduced abundance of the TPO protein and loss of TPO enzyme activity in a Malaysian–Chinese family with goitrous hypothyroidism. The aim of our study was to provide further data on the incidence of the c.2268dup mutation in a cohort of Malaysian–Chinese and its possible phenotypic effects. Setting Cohort study. Participants Twelve biologically unrelated Malaysian–Chinese patients with congenital hypothyroidism were recruited in this study. All patients showed high thyrotropin and low free thyroxine levels at the time of diagnosis with proven presence of a thyroid gland. Primary outcome measure Screening of the c.2268dup mutation in the TPO gene in all patients was carried out using a PCR–direct DNA sequencing method. Secondary outcome measure Further screening for mutations in other exonic regions of the TPO gene was carried out if the patient was a carrier of the c.2268dup mutation. Results The c.2268dup mutation was detected in 4 of the 12 patients. Apart from the c.2268dup and a previously documented mutation (c.2647CT), two novel TPO alterations, c.670_672del and c.1186CT, were also detected in our patients. In silico analyses predicted that the novel alterations affect the structure/function of the TPO protein. Conclusions The c.2268dup mutation was detected in approximately one-third of the Malaysian–Chinese patients with thyroid dyshormonogenesis. The detection of the novel c.670_672del and c.1186CT alterations expand the mutation spectrum of TPO associated with thyroid dyshormonogenesis.
机译:目的甲状腺过氧化物酶(TPO)基因中的c.2268dup突变是台湾甲状腺功能异常的患者中最常见的TPO改变。这些患者的祖先被认为来自中国南部省份。我们以前的研究表明,这种突变导致甲状腺机能减退的马来西亚华人家庭中TPO蛋白的丰度降低,TPO酶活性降低。我们的研究目的是提供更多有关马来西亚华人队列中c.2268dup突变的发生率及其可能的表型效应的数据。进行队列研究。参与者本研究招募了12名与生物学无关的马来西亚-中国先天性甲状腺功能减退症患者。所有患者在诊断时表现出高促甲状腺素和低游离甲状腺素水平,并证实存在甲状腺。主要结局指标使用PCR直接DNA测序方法对所有患者的TPO基因中的c.2268dup突变进行筛选。二级结果测量如果患者是c.2268dup突变的携带者,则进一步筛选TPO基因其他外显子区域的突变。结果12例患者中有4例检测到c.2268dup突变。除了c.2268dup和先前记录的突变(c.2647C> T),在我们的患者中还检测到两个新的TPO改变,即c.670_672del和c.1186C> T。在计算机分析中预测,新的改变会影响TPO蛋白的结构/功能。结论在大约三分之一的马来西亚华裔甲状腺功能异常的患者中检测到c.2268dup突变。新的c.670_672del和c.1186C> T突变的检测扩大了与甲状腺功能异常发生相关的TPO的突变谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号